ACADIA Pharmaceuticals, Inc. (ACAD)
23.99
-0.34
(-1.40%)
USD |
NASDAQ |
Feb 20, 16:00
24.40
+0.41
(+1.71%)
After-Hours: 20:00
ACADIA Pharmaceuticals SG&A Expense (Quarterly) : 133.40M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.024M |
| Dynavax Technologies Corp. (DELISTED) | 40.09M |
| Axsome Therapeutics, Inc. | 150.24M |
| Rhythm Pharmaceuticals, Inc. | 52.42M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |